M
Med fusion
Helps the healthcare community redefine the delivery of clinical laboratory and trial services
About Med fusion
Med Fusion, acquired by Quest Diagnostics on July 21, 2017, operates as an integrated Molecular Center of Excellence and clinical trials organization. The company provides advanced laboratory diagnostics and comprehensive support services to healthcare providers and biotech pharmaceutical companies. Med Fusion's full-service clinical laboratory includes a dedicated team for test development and validation, as well as reference lab services such as pathology and molecular response testing.
Med Fusion serves a diverse range of clients, primarily focusing on healthcare providers and biotech firms that require precise and reliable diagnostic services. The company operates within the healthcare and biotechnology markets, leveraging its expertise to meet the specific needs of these sectors.
The business model of Med Fusion revolves around offering specialized diagnostic services and clinical trial support. Revenue is generated through service contracts with healthcare providers and biotech companies, who rely on Med Fusion's advanced laboratory capabilities to enhance patient care and accelerate drug development processes.
Source: Dealroom company dataAt a glance
- Status
- Acquired
- Founded
- 2010
- Headquarters
- Lewisville, United States
- Employees
- 82
- Open positions
- None listed
- Dealroom signal
- 31.5/100
- Industry
- Health
- Sub-industry
- BioTechnology
- Sector
- Biotech & Life Sciences, Testing, Biotechnology, Oncology, Precision Medicine, Arts & Culture, Biotech and Pharma, Hard Tech, medical testing, DT and LS, science-based
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| ACQUISITIONOther financing | Jun 2017 | $0 | — | Quest Diagnostics | — |
| LATE VCOther financing | Jan 2014 | $61M | $245M | Undisclosed | — |
Growth signals
Latest recorded traffic for Med fusion is 3.9K monthly website visits, up 5.4% over the last three months. Med fusion's team declined 27.4% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Other known investors1 additional known investor
Quest Diagnostics
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Med fusion on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Med fusion’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.